The data is big,please wait a moment......
| EWAS ID | GO ID | Class | Disease/Phenotype [sample size n] |
Sample groups (case/control, trait, cell type etc.) |
Categories | GO Term Name | GO Term Gene Number | Gene Number Annotated In The GO Term | Pvalue | |
| Group1 [sample size n] |
Group2 [sample size n] |
|||||||||
| EWAS717 | GO:0016818 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
molecular_function | hydrolase activity- acting on acid anhydrides- in phosphorus-containing anhydrides | 725 | 488 | 0.000314 |
| EWAS717 | GO:0017076 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
molecular_function | purine nucleotide binding | 1736 | 1185 | 0.000000 |
| EWAS717 | GO:0019899 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
molecular_function | enzyme binding | 697 | 485 | 0.000002 |
| EWAS717 | GO:0017157 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
biological_process | regulation of exocytosis | 49 | 40 | 0.000624 |
| EWAS717 | GO:0017171 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
molecular_function | serine hydrolase activity | 156 | 115 | 0.000410 |
| EWAS717 | GO:0018108 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
biological_process | peptidyl-tyrosine phosphorylation | 115 | 87 | 0.000400 |
| EWAS717 | GO:0018212 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
biological_process | peptidyl-tyrosine modification | 117 | 89 | 0.000250 |
| EWAS717 | GO:0019002 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
molecular_function | GMP binding | 12 | 12 | 0.000000 |
| EWAS717 | GO:0019199 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
molecular_function | transmembrane receptor protein kinase activity | 80 | 63 | 0.000277 |
| EWAS717 | GO:0019216 | disease | down syndrome (DS) [n=23] |
Down syndrome(Adult;Cerebellar cortex;Whole grey matter) [n=13] |
Normal(Adult;Cerebellar cortex;Whole grey matter) [n=10] |
biological_process | regulation of lipid metabolic process | 133 | 104 | 0.000011 |